| Filed On | Filing |
|---|---|
| 31 Jul 2026 |
Form 4: Nighan Warren Jr, SVP Quality and Regulatory
Sold 23,370 shares ($344K) |
| 24 Jul 2026 |
Form 4: Piccinini Laura, SVP International
Received 8,047 shares by exercise or conversion · Gave up 4,506 shares to cover exercise price or tax ($62.3K) |
| 24 Jul 2026 |
Form 4: Nighan Warren Jr, SVP Quality and Regulatory
Received 5,694 shares by exercise or conversion · Gave up 1,671 shares to cover exercise price or tax ($23.1K) |
| 24 Jul 2026 |
Form 4: Trowbridge Stephen A, EVP and CFO
Received 16,296 shares by exercise or conversion · Gave up 8,319 shares to cover exercise price or tax ($115K) |
| 24 Jul 2026 |
Form 4: Clemmer James C, Director
Received 52,358 shares by exercise or conversion · Gave up 26,728 shares to cover exercise price or tax ($369K) |
| 24 Jul 2026 |
Form 4: Campbell Chad Thomas, SVP/GM, Vascular Access
Received 6,466 shares by exercise or conversion · Gave up 2,330 shares to cover exercise price or tax ($32.2K) |
| 22 Jul 2026 |
Form 4: Reed Jan Stern, Director
Received 11,887 shares as a grant or award |
| 22 Jul 2026 |
Form 4: Licitra Karen A, Director
Received 11,887 shares as a grant or award |
| 22 Jul 2026 |
Form 4: Johnson Wesley, Director
Received 11,887 shares as a grant or award |
| 22 Jul 2026 |
Form 4: Donnelly Howard W, Director
Received 11,887 shares as a grant or award |
| 22 Jul 2026 |
Form 4: Burgess Lorinda, Director
Received 11,887 shares as a grant or award |
| 22 Jul 2026 |
Form 4: Auen Eileen O'Shea, Director
Received 11,887 shares as a grant or award |
| 22 Jul 2026 |
Form 4: Tarnoff Michael E, Director
Received 11,887 shares as a grant or award |
| 22 Jul 2026 |
Form 4: Trowbridge Stephen A, EVP and CFO
Received 53,257 shares as a grant or award · Granted 53,257 Performance Right |
| 22 Jul 2026 |
Form 4: Piccinini Laura, SVP International
Received 19,860 shares as a grant or award · Granted 19,860 Performance Right |
| 22 Jul 2026 |
Form 4: Nighan Warren Jr, SVP Quality and Regulatory
Received 17,966 shares as a grant or award · Granted 17,966 Performance Right |
| 22 Jul 2026 |
Form 4: Campbell Chad Thomas, SVP/GM, Vascular Access
Received 16,081 shares as a grant or award · Granted 16,081 Performance Right |
| 22 Jul 2026 |
Form 4: Weiss Lawrence T, SVP, Chief Legal Officer
Received 21,288 shares as a grant or award · Granted 21,288 Performance Right |
| 21 Jul 2026 |
Form 4: Weiss Lawrence T, SVP, Chief Legal Officer
Gave up 2,267 shares to cover exercise price or tax ($32.1K) |
| 21 Jul 2026 |
Form 4: Trowbridge Stephen A, EVP and CFO
Gave up 7,840 shares to cover exercise price or tax ($111K) · Gave up 3,510 shares to cover exercise price or tax ($47.4K) · Gave up 717 shares to cover exercise price or tax ($9.83K) |
Loading...